Homepage  Homepage     Search on site  Search on site     To write the letter  To write the letter     Site map  Site map
Agro Perspectiva
We are on: 
   
 


Home > News

Bayer announces agreements to resolve major legacy Monsanto litigation

25.06.2020 12:50 "Agro Perspectiva" (Kyiv) Bayer announced a series of agreements that will substantially resolve major outstanding Monsanto litigation, including U. S. Roundup product liability litigation, dicamba drift litigation and PCB water litigation. The main feature is the U. S. Roundup resolution that will bring closure to approximately 75% of the current Roundup litigation involving approximately 125,000 filed and unfiled claims overall. The resolved claims include all plaintiff law firms leading the Roundup federal multi-district litigation (MDL) or the California bellwether cases, and those representing approximately 95% of the cases currently set for trial, and establish key values and parameters to guide the resolution of the remainder of the claims as negotiations advance. The resolution also puts in place a mechanism to resolve potential future claims efficiently. The company will make a payment of $8.8 billion to $9.6 billion to resolve the current Roundup litigation, including an allowance expected to cover unresolved claims, and $1.25 billion to support a separate class agreement to address potential future litigation. The Roundup class agreement will be subject to approval by Judge Vince Chhabria of the U. S. District Court for the Northern District of California. The resolutions were approved unanimously by Bayers Board of Management and Supervisory Board with input from its Special Litigation Committee. The agreements contain no admission of liability or wrongdoing.

«First and foremost, the Roundup settlement is the right action at the right time for Bayer to bring a long period of uncertainty to an end,» said Werner Baumann, Chief Executive Officer of Bayer. «It resolves most current claims and puts in place a clear mechanism to manage risks of potential future litigation. It is financially reasonable when viewed against the significant financial risks of continued, multi-year litigation and the related impacts to our reputation and to our business. The decision to resolve the Roundup litigation enables us to focus fully on the critical supply of healthcare and food. It will also return the conversation about the safety and utility of glyphosate-based herbicides to the scientific and regulatory arena and to the full body of science.»

«The Roundup agreements are designed as a constructive and reasonable resolution to a unique litigation,» said Kenneth R. Feinberg, court-appointed mediator for the settlement talks. «The separate, independent settlements of the current claims are unique and a tribute to Bayer. The significant progress made to date — which exceeds the initial participation rates of other claims resolution proceedings — provides a robust framework that will enable the parties to bring closure to the current Roundup litigation in due course.»

Resolution of Roundup litigation

The multi-step Roundup resolution includes several elements. The agreements will resolve the vast majority of the current litigation in U.S. federal and state courts, including both plaintiffs with filed cases and parties who have retained counsel but not yet filed their claims in court. Those participating in the settlement will be required to dismiss their cases or agree not to file. The range of $8.8 billion to $9.6 billion covers both the agreements already signed and those that are still under negotiation. It also reflects the fact that the number of claimants who are eligible to receive compensation under these agreements wont be known until the claims process is well underway. The claims still subject to negotiation largely consist of cases generated by TV advertising and for which plaintiffs law firms have provided little or no information on the medical condition of their clients, and/or cases held by law firms with small inventories.

The three cases that have gone to trial — Johnson, Hardeman and Pilliod — will continue through the appeals process and are not covered by the settlement. It is important for the company to continue these cases as the appeals will provide legal guidance going forward. In an appellate court filing, the U.S. government expressed its specific support for the companys preemption arguments, asserting that state law warning claims in the Roundup litigation conflict with U.S. federal law, requiring no cancer warning, and must be dismissed. Just this week, a federal judge in California found that the weight of scientific evidence does not support the states Proposition 65 cancer warning requirement for glyphosate-based herbicides — a ruling that reinforces the very arguments the company has made at trial.

Potential future cases will be governed by a class agreement which is subject to court approval. The agreement includes the establishment of a class of potential future plaintiffs and the creation of an independent Class Science Panel. The Class Science Panel will determine whether Roundup can cause non-Hodgkins lymphoma (NHL), and if so, at what minimum exposure levels. The materials considered by the Class Science Panel that Bayer has permission to disclose or are in the public domain will be posted on a public website. Both the class and company will be bound by the Class Science Panels determination on this question of general causation, taking this decision out of the jury trial setting and putting it back in the hands of expert scientists. If the Class Science Panel determines that a causal connection between Roundup and NHL is not established, class members will be barred from claiming otherwise in any future litigation against the company. The Class Science Panels determination is expected to take several years. Class members will not be permitted to proceed with Roundup claims prior to the Class Science Panels determination, and cannot seek punitive damages. The agreed funding is capped at $1.25 billion and will support research into treatment of NHL, NHL diagnostic programs in underserved areas, and assistance payments to class members who develop NHL before the Class Science Panels determination and are eligible on a need basis for assistance during that period.

The company said that before deciding to settle, it considered the alternative course of continuing to litigate Roundup cases. In the companys risk assessment, potential negative outcomes of further litigation, including more advertising and growing numbers of plaintiffs, upwards of twenty trials per year and uncertain jury outcomes, and associated reputational and business impacts, likely would substantially exceed the settlement and related costs.

«Taking account of various options, I am convinced this plan provides a comprehensive, reasonable solution to the complex, contested issues presented by this litigation,» said attorney John Beisner, a consultant to Bayers Supervisory Board and a mass tort expert who leads Skadden, Arps, Slate, Meagher & Flom LLPs Mass Torts, Insurance and Consumer Litigation Practice Group.

«Supported by our external advisor John Beisner and the Litigation Committee, the Supervisory Board has closely followed the Roundup litigation, as well as the dicamba and PCB litigation, and has provided counsel to the Board of Management on these matters. The Supervisory Board unanimously agrees with our Board of Management that all three settlements are in the best interest of the company and our stakeholders,» said Norbert Winkeljohann, Chairman of Bayers Supervisory Board.

Baumann added: «Our company is grounded in the well-being of our customers. As a science-based company committed to improving peoples health, we have great sympathy for anyone who suffers from disease, and we understand their search for answers. At the same time, the extensive body of science indicates that Roundup does not cause cancer, and therefore, is not responsible for the illnesses alleged in this litigation. We stand strongly behind our glyphosate-based herbicides, which are among the most rigorously studied products of their kind, and four decades of science support their safety and that they are not carcinogenic.» Indeed, in its Interim Registration Review Decision, issued in January, the U. S. Environmental Protection Agency (EPA) accurately concluded that it «did not identify any human health risks from exposure to glyphosate.»

Customers, including farmers and other professional users who depend on glyphosate-based herbicides for their livelihoods, will see no change in the availability of Roundup products under the Roundup agreements announced today. Meanwhile, Bayer remains committed to offering customers more choices and announced last year an investment of approximately EUR 5 billion over a ten-year period to develop additional methods to manage weeds as part of an integrated approach to sustainable agriculture.

Resolution of dicamba litigation

Bayer also announced a mass tort agreement to settle the previously disclosed dicamba drift litigation involving alleged damage to crops. The company will pay up to a total of $400 million to resolve the multi-district litigation pending in the U. S. District Court for the Eastern District of Missouri and claims for the 2015–2020 crop years. Claimants will be required to provide proof of damage to crop yields and evidence that it was due to dicamba in order to collect. The company expects a contribution from its co-defendant, BASF, towards this settlement.

The only dicamba drift case to go to trial — Bader Farms — is not included in this resolution. The company believes the verdict in Bader Farms is inconsistent with the evidence and the law and will continue to pursue post-trial motions and an appeal, if necessary.

Bayer stands strongly behind the safety and utility of its XtendiMax herbicide with VaporGrip technology and continues to enhance training and education efforts to help ensure growers use these products successfully. The company is settling the pending dicamba drift cases to be able to focus on the needs of its customers.

Resolution of PCB litigation

Bayer also announced a series of agreements that resolve cases representing most of the companys exposure to PCB water litigation. Monsanto legally manufactured PCBs until ceasing their production in 1977. One agreement establishes a class that includes all local governments with EPA permits involving water discharges impaired by PCBs. Bayer will pay a total of approximately $650 million to the class, which will be subject to court approval.

At the same time, the company has entered into separate agreements with the Attorneys-General of New Mexico, Washington, and the District of Columbia to resolve similar PCB claims. For these agreements, which are separate from the class, Bayer will make payments that together total approximately $170 million.

Funding sourced from free cash flow and Animal Health divestment

Cash payments related to the settlements are expected to start in 2020. Bayer currently assumes that the potential cash outflow will not exceed $5 billion in 2020 and $5 billion in 2021; the remaining balance would be paid in 2022 or thereafter. In order to finance these payments which are subject to tax treatment, Bayer can make use of existing surplus liquidity, future free cash flows, the proceeds from the Animal Health divestment, and additional bond issuances, which will provide flexibility in managing the settlement payments as well as upcoming debt maturities.

Based on publications by the rating agencies and the companys communication with them, Bayer expects to keep investment grade credit ratings. With its strong underlying business, the company intends to keep its dividend policy. At the same time, deleveraging the balance sheet remains a high priority.

Bayer: Well positioned for the future

«As we work to put this major litigation behind us, Bayer can set a course for the future and tackle the global challenges we face in both health and nutrition — not only today as we confront the COVID-19 pandemic, but also long-term, as we work to improve quality of life for a growing and aging population of an estimated 10 billion people by 2050,» said Baumann. «More than 100,000 people put their energies into making our vision of Health for all, Hunger for none come true with medicines and agricultural products. We believe that science and innovation will be critical to the future, just as they have been for Bayer in serving customers and patients over nearly 160 years. We are committed to addressing these challenges in a responsible manner, both to help meet the UNs sustainable development goals, and maintain the transparency and constructive engagement with stakeholders that is essential to sustain public trust in our products and in our company.»

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros.

Agro Perspectiva

< Decline of industrial production in Ukraine slows to 12.2% in May statistics All news for
25.06.2020
Cargill launches first chocolate manufacturing operation in Asia, with growth plans across region >

14.05.2021  
14:15 ASTARTA Started Raw Sugar Processing
12.05.2021  
14:01 For the MY 2021/22 forecasts Bangladeshs rice production to increase, assuming friendly weather and increased yield
12:51 Total Latvian wheat, rye, mixed grains, triticale, barley, corn, and oat production in MY 2021/22 is forecast at 3.2 MMT
07.05.2021  
13:22 Global cereal markets tighten as demand remains strong in 2020/21
12:25 International food prices continue rising in April
06.05.2021  
15:38 New Zealand. Total milk production is forecast at 22.2 MMT
05.05.2021  
16:47 CNH Industrial. Consolidated revenues of $7.5 billion (up 37% compared to Q1 2020)
13:21 Australia. Wheat production is forecast at 27 MMT in MY 2021/22
30.04.2021  
14:21 ASTARTA Finished Sugar Beet Planting
29.04.2021  
11:49 Manitou Group: Q121 revenues of 471m, +12% vs. Q120
11:39 BASF increased sales by 2.6 billion compared with the first quarter of 2020 to 19.4 billion
28.04.2021  
17:00 Spain: Spanish Cheese Exports May Rebound in 2021
27.04.2021  
16:47 Argentina. Wheat production is estimated at 20.5 million tons in 2021/2022
26.04.2021  
16:35 Small family farmers produce a third of the worlds food
10:09 Industrial production in Ukraine 2.1% up in March 2021 - statistics
24.04.2021  
07:20 Finance Ministry proposes to change criteria for land valuation in settlements by 2023
22.04.2021  
11:28 Giving a voice to soil organisms our silent allies in the fight against hunger
21.04.2021  
09:53 NBU sends UAH 24.4 bln of profit to state budget
20.04.2021  
11:50 Vietnam. Soybean meal demand for feed use is forecast to increase in MY2021/22 as the swine herd repopulates
16.04.2021  
14:11 NBU raises key policy rate to 7.5%
14.04.2021  
17:10 Brazil Meat Exports Continue to Grow
13.04.2021  
16:25 Coffee is considered a priority crop by the Angolan Government
12.04.2021  
11:20 Brazil Soybean Exports Record Large in March
10:18 Burma Rice Exports Disrupted Amid Coup
08.04.2021  
21:05 Positive cereal crop prospects in 2021
20:35 Global food prices rise for 10th month in a row
04.04.2021  
10:16 A spicy agricultural heritage: theres more to wasabi than meets the eye
02.04.2021  
16:00 Turkey. Cattle numbers to increase 1 percent in 2021 to 18.3 million head - USDA
13:25 Japan To Begin Enforcement of Organic Regulations for Turkey Products
26.03.2021  
13:55 Korea. Overall demand for beef and pork remains strong
24.03.2021  
15:55 Cargill purchases Precision Ag, expanding its Canadian crop inputs business
23.03.2021  
21:28 Ukraine's GDP down by 4% in 2020 statistics
21:15 Green Climate Fund approves $80 million in FAO-led projects in Congo and Jordan
20:31 Ukrainian banks see profit fall by 60% in Jan-Feb - NBU
21.03.2021  
09:49 Business and govt agree to stabilize prices for socially important goods - EBA
16.03.2021  
16:35 Mexicos chicken meat production, consumption, and imports are projected for 2021
10.03.2021  
21:07 India Corn Exports Competitive Regionally
07.03.2021  
23:15 Early estimate points to record 2021 wheat output
22:43 FAO Food Price Index rises for ninth consecutive month in February
04.03.2021  
12:33 BASF achieved its 2020 Palm Commitment
01.03.2021  
11:43 BASF Group: Strong performance in Q4 2020 due to higher volumes and prices
16.02.2021  
11:05 Kernel asks AMCU for permission to buy CascadeAgro, 12 more farms of Khomutynnik
13.02.2021  
18:36 Ukraine: EIB provides 320 million EURO for COVID-19 vaccines and improvements in operational resilience at Boryspil International Airport
11.02.2021  
09:47 Soybean Buyers Turn Attention to Brazils 2021 Harvest
29.01.2021  
11:15 Global orange production for 2020/21 is forecast to rise 3.6 million MT from the previous year to 49.4 million
28.01.2021  
15:20 USDA attache increased its estimate for South Africas 2020/21 MY total corn crop by 14% to 16 million tons
26.01.2021  
17:10 Economy Ministry announces market agreement to limit corn export from Ukraine in 2020/2021 MY to 24 mln tonnes
13:33 China Lowers Applied MFN Tariff Rates and Revises Out of Quota TRQ Rates
21.01.2021  
11:28 Ukraine plans to return to sending IMF borrowing into NBU FX reserves by 2023 Finance minister
09:15 Honey exports from Ukraine increase in monetary terms by 27.2% in 2020

Also available: 


NewsNews - News - News - News - News - News
BriefWeekly Reports - Free article
SubscriptionTariff - News&Reports
AdvertisingMagazine - Site
ConferencesForum AGRO-2013 - DAIRY WORLD-2008 - FERTILIZERS-2010
Statistics
For our clientsAgroNewsDaily - Ukrainian Grain&Oilseed Market - Fertilizers - Milk Monthly - Milk Weekly
About usAbout project - Contact
2002 -2021 © Agrarika, ltd.
tel.: +380 44 5934543; +380 44 5934540
e-mail: client@agroperspectiva.com